| The emergence of clinical practice guidelines G Weisz, A Cambrosio, P Keating, L Knaapen, T Schlich, VJ Tournay The Milbank Quarterly 85 (4), 691-727, 2007 | 290 | 2007 |
| How can clinical practice guidelines be adapted to facilitate shared decision making? A qualitative key-informant study T van der Weijden, AH Pieterse, MS Koelewijn-van Loon, L Knaapen, ... BMJ quality & safety 22 (10), 855-863, 2013 | 124 | 2013 |
| Being ‘evidence-based’in the absence of evidence: The management of non-evidence in guideline development L Knaapen Social Studies of Science 43 (5), 681-706, 2013 | 109 | 2013 |
| Diagnosing and treating premenstrual syndrome in five western nations G Weisz, L Knaapen Social science & medicine 68 (8), 1498-1505, 2009 | 98 | 2009 |
| Evidence‐Based medicine or Cookbook medicine? addressing concerns over the standardization of care L Knaapen Sociology Compass 8 (6), 823-836, 2014 | 82 | 2014 |
| Pragmatic evidence and textual arrangements: A case study of French clinical cancer guidelines L Knaapen, H Cazeneuve, A Cambrosio, P Castel, B Fervers Social science & medicine 71 (4), 685-692, 2010 | 58 | 2010 |
| The biomedical standardization of premenstrual syndrome L Knaapen, G Weisz Studies in History and Philosophy of Science Part C: Studies in History and …, 2008 | 44 | 2008 |
| How do guideline developers identify, incorporate and report patient preferences? An international cross-sectional survey J Blackwood, MJ Armstrong, C Schaefer, ID Graham, L Knaapen, ... BMC Health Services Research 20, 1-10, 2020 | 33 | 2020 |
| Three conceptual models of patient and public involvement in standard-setting: from abstract principles to complex practice L Knaapen, P Lehoux Science as Culture 25 (2), 239-263, 2016 | 29 | 2016 |
| European regulation and harmonization of clinical practice guidelines L Knaapen European Union Public Health Policy, 64-80, 2013 | 7 | 2013 |
| Science needs more external evaluation, not less L Knaapen Social Science Information 60 (3), 338-344, 2021 | 3 | 2021 |
| Patient and public involvement in guidelines C Schaefer, L Knaapen Guidel Int Netw, 2015 | 2 | 2015 |
| How to involve patients and the public in dissemination and implementation of guidelines K Graham, S Twaddle, CM Davino-Ramaya, L Knaapen GIN PUBLIC Toolkit: Patient and Public Involvement in Guidelines, 60, 2012 | 1 | 2012 |
| Interdisciplinary study of the impact of the cultural and organization context on the elaboration of clinical practical recommendations in oncology H Cazeneuve, M Remy-Stockinger, L Knaapen, P Castel, A Cambrosio, ... BULLETIN DU CANCER 95, S46-S47, 2008 | | 2008 |
| Vers une pharmaceuticalisation de la société?: Le médicament comme objet social F Chabrol, J Collin, PM David, M Gagnon, G Girard, F Guis, A Guta, ... Vers une pharmaceuticalisation de la société?, 0 | | |
| 第 2 章: 患者視点についての質的研究をガイドラインに取 L Knaapen, CJ Colvin, J Cowl, T van der Weijden ガイドライン作成における, 28, 0 | | |
| 第 3 章: ガイドライン作成において患者・市民を参集し支 SC Page, J Cowl, L Knaapen ガイドライン作成における, 40, 0 | | |
| How to involve patients and the public in dissemination and implementation of guidelines (2012) K Graham, S Twaddle, CM Davino-Ramaya, L Knaapen GIN Public Toolkit, 115, 0 | | |
| How guidelines can support patient involvement in the clinic (2012) T van der Weijden, M Koelewijn-van Loon, L Knaapen, A Boivin GIN Public Toolkit, 135, 0 | | |
| How to include qualitative research on patient views in guidelines (2015) L Knaapen, CJ Colvin, J Cowl, T van der Weijden GIN Public Toolkit, 28, 0 | | |
